Sie versprachen, die Rechte an ihrem COVID-Impfstoff zu spenden, und verkauften sie dann an die Pharmaindustrie linkezeitung.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from linkezeitung.de Daily Mail and Mail on Sunday newspapers.
Sie versprachen, die Rechte an ihrem COVID-Impfstoff zu spenden, und verkauften sie dann an die Pharmaindustrie linkezeitung.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from linkezeitung.de Daily Mail and Mail on Sunday newspapers.
Yves here. Aside from Bill Gates’ unsavory role in defending the right of Big Pharma to rake in profits at the expense of the public during a massive public health crisis, there is also the wee problem of determining what selling a vaccine at cost would amount to. As a client put it, pointing to a conference room chair, “What does that chair cost? I can make it cost whatever I want to.” Specifically, big companies have considerable latitude as to the costs and overheads they allocate to products and businesses (that’s one reason they regularly have to call in McKinsey, the internal practices so distort the real economics that they need to hire a consultant to untangle the mess). Many years back, a colleague had been in the executive office of Bristol Myers when it owned Clairol. She described that hair color was so profitable (you make it for pennies a box and sell it for dollars a box) that Bristol Myers allocated every overhead expense it conceivably could, to boost the reported pharma profits, to which Wall Street assigned a higher multiple. Imagine the process working the other way with vaccine accounting.
Die neue Coronavirus-Variante: Was wir über die Mutation wissen | Freie Presse freiepresse.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freiepresse.de Daily Mail and Mail on Sunday newspapers.